Show simple item record

dc.date.accessioned 2017-09-19T14:37:14Z
dc.date.available 2017-09-19T14:37:14Z
dc.identifier.uri https://digital.cic.gba.gob.ar/handle/11746/6168
dc.title DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations en
dc.type Artículo es
dcterms.abstract Controversy always existed on the utility of chemically induced mouse mammary carcinogenesis models as valid equivalents for the study of human breast cancer. Here, we performed whole exome and RNA sequencing on long latency mammary tumors (218 ± 27 days) induced by the carcinogen 7,12-Dimethylbenzathracene (DMBA) and short latency tumors (65 ± 11 days) induced by the progestin Medroxyprogesterone Acetate (MPA) plus DMBA in CD2F1 mice. Long latency tumors displayed a high frequency of <em>Pi3kca</em> and/or <em>Pten</em> mutations detected in 11 of 13 (85%) long latency cases (14/22, 64% overall). Eighty-two percent (9/11) of tumors carried the <em>Pik3ca</em> H1047L/R hot-spot mutation, as frequently found in human breast cancer. These tumors were luminal-like and mostly ER/PR+, as in humans. Transcriptome profiling indicated a significant activation of the PI3K-Akt pathway (p=3.82e-6). On the other hand MPA+DMBA induced short latency tumors displayed mutations in cancer drivers not commonly found mutated in human breast cancer (e.g. <em>Hras</em> and <em>Apc</em>). These tumors were mostly basal-like and MPA exposure led to <em>Rankl</em> overexpression (60 fold induction) and immunosuppressive gene expression signatures. In summary, long latency DMBA induced mouse mammary tumors reproduce the molecular profile of human luminal breast carcinomas representing an excellent preclinical model for the testing of PIK3CA/Akt/mTOR pathway inhibitory therapies and a good platform for the developing of additional preclinical tools such as syngeneic transplants in immunocompetent hosts. en
dcterms.extent p. 64289-64299 es
dcterms.issued 2016-08
dcterms.language Inglés es
dcterms.license Attribution 4.0 International (BY 4.0) es
dcterms.publisher Impact Journals es
dcterms.subject mammary tumors en
dcterms.subject DMBA en
dcterms.subject MPA en
dcterms.subject Pik3ca en
dcterms.subject Pten en
cic.version info:eu-repo/semantics/publishedVersion es
dcterms.creator.author Abba, Martín Carlos es
dcterms.creator.author Zhong, Yi es
dcterms.creator.author Lee, Jaeho es
dcterms.creator.author Kil, Hyunsuk es
dcterms.creator.author Lu, Yue es
dcterms.creator.author Takata, Yoko es
dcterms.creator.author Simper, Melissa S. es
dcterms.creator.author Gaddis, Sally es
dcterms.creator.author Shen, Jianjun es
dcterms.creator.author Aldaz, C. Marcelo es
cic.lugarDesarrollo Centro de Investigaciones Inmunológicas Básicas y Aplicadas es
dcterms.subject.materia Ciencias Médicas es
dcterms.identifier.url Recurso completo es
dcterms.identifier.other DOI 10.18632/oncotarget.11733 es
dcterms.isPartOf.issue vol. 7, no. 39 es
dcterms.isPartOf.series Oncotarget es
cic.isPeerReviewed true es
cic.isFulltext true es


Files

  • Icon

    Documento completo 

    PDF file (2.560Mb)

  • This item appears in the following Collection(s)

    Show simple item record